Full Press Release Details
Leiden, theNetherlands, October 30, 2025:Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming management will participate in the Jefferies Global Healthcare Conference in London, UK, on November 17-20, 2025.
Fabrice Chouraqui, Chief Executive Officer, will participate in a Fireside Chat Q&A session on Wednesday, November 19 at 10:00 GMT/11:00 CET. A live webcast and replay of the presentation can be found in the “Upcoming Events” and “News” sections of Pharming’s website.
For more information about the conference, or to schedule a one-to-one meeting with Pharming’s management team, please contact Investor Relations atinvestor@pharming.comor your Jefferies representative.
About Pharming Group N.V.Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. We are developing and commercializing a portfolio of innovative medicines, including small molecules and biologics. Pharming is headquartered in Leiden, the Netherlands, with a significant proportion of its employees based in the U.S.
For more information, visitwww.pharming.comand find us onLinkedIn.
For further public information, contact:Investor RelationsMichael Levitan, VP Investor Relations & Corporate CommunicationsT: +1 (908) 705 1696E:investor@pharming.com
Media RelationsGlobal: Saskia Mehring, Corporate Communications ManagerT: +31 6 28 32 60 41E:media.relations@pharming.comU.S.: Ethan Metelenis (Precision AQ on behalf of Pharming)T: +1 (917) 882-9038Netherlands: Leon Melens (LifeSpring Life Sciences Communication on behalf of Pharming)T: +31 6 53 81 64 27